NEW GAMMA-AMINOBACYRIC ACID RECEPTOR MODULERS TYPE A AGAINST MOOD DISORDERS

摘要

The present invention relates to new selective negative allosteric modulators of GABA receptors containing the alpha5 subunit, which are deuterated to improve their medical properties by increasing their half-life, which makes them suitable as fast-acting pharmaceutical agents for treating depression-related disorders.